Prolonged Exposure Therapy for PTSD and Opioid Use Disorder
Post Traumatic Stress Disorder, Opioid-use Disorder
About this trial
This is an interventional treatment trial for Post Traumatic Stress Disorder focused on measuring Post Traumatic Stress Disorder, Opioid-use Disorder, Prolonged Exposure Therapy, Opioid Agonist Therapy, Financial Incentives, Substance Use
Eligibility Criteria
Inclusion Criteria:
- >18 years old
- currently maintained on a stable methadone or buprenorphine dose for >1 month prior to the study
- endorse >1 lifetime traumatic event
- meet current DSM-V posttraumatic stress disorder criteria
Exclusion Criteria:
- Presence of an acute psychotic disorder, bipolar disorder with an active manic episode
- imminent risk for suicide
- a medical condition that may interfere with consent or participation
- illiteracy in English
Sites / Locations
- University of VemontRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Active Comparator
Experimental
OAT as usual
OAT+PET
OAT+PET+
Those randomized to OAT as usual will continue to receive standard buprenorphine or methadone treatment and complete assessments of PTSD symptom severity, psychosocial functioning and drug use at intake and Study Weeks 4, 8, and 12.
In addition to receiving OAT and completing monthly assessments, OAT+PET participants will receive 12 weekly PET sessions with a trained therapist.
OAT+PET+ participants will receive the procedures for the OAT+PET group plus monetary incentives contingent upon completion of PET sessions